Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis Grazyna Bochenek, MD, PhD, Joanna Kuschill-Dziurda, MD, Krystyna Szafraniec, PhD, Hanna Plutecka, PhD, Andrzej Szczeklik, MD, PhD, Ewa Nizankowska-Mogilnicka, MD, PhD Journal of Allergy and Clinical Immunology Volume 133, Issue 1, Pages 98-103.e6 (January 2014) DOI: 10.1016/j.jaci.2013.07.004 Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Asthma treatment in the respective classes, as identified by LCA. CS, Corticosteroids; ICS, inhaled corticosteroids; OCS, oral corticosteroids. Journal of Allergy and Clinical Immunology 2014 133, 98-103.e6DOI: (10.1016/j.jaci.2013.07.004) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 2 Levels of asthma severity in the respective classes, as identified by LCA. Journal of Allergy and Clinical Immunology 2014 133, 98-103.e6DOI: (10.1016/j.jaci.2013.07.004) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 3 Urinary logLTE4 levels in the 4 classes, as identified by LCA. Values are presented as mean (95% CIs). Journal of Allergy and Clinical Immunology 2014 133, 98-103.e6DOI: (10.1016/j.jaci.2013.07.004) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions